BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29490995)

  • 21. Pseudohypoparathyroidism type 1a.
    Singla M; Garg G; Gupta A
    QJM; 2018 May; 111(5):331-333. PubMed ID: 29474689
    [No Abstract]   [Full Text] [Related]  

  • 22. A patient with extensive cerebral calcification due to pseudohypoparathyroidism: a case report.
    De Silva SW; De Silva SDN; De Silva CE
    BMC Endocr Disord; 2019 Dec; 19(1):142. PubMed ID: 31856822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pseudohypoparathyroidism or vitamin D deficiency? Report of one case].
    López JM; Carrasco CM
    Rev Med Chil; 2004 Dec; 132(12):1527-31. PubMed ID: 15743166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical effects of calcium and vitamin D supplementation in elderly, institutionalized, vitamin D-deficient patients.
    Chapuy MC; Chapuy P; Thomas JL; Hazard MC; Meunier PJ
    Rev Rhum Engl Ed; 1996 Feb; 63(2):135-40. PubMed ID: 8689285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe early-onset overgrowth in a case of pseudohypoparathyroidism type 1b, caused by STX16 deletion.
    Vos N; Menke LA; Mooij CF; van den Akker ELT; Alders M; van Haelst MM
    Am J Med Genet A; 2023 May; 191(5):1476-1478. PubMed ID: 36807968
    [No Abstract]   [Full Text] [Related]  

  • 26. Sporadic pseudohypoparathyroidism type 1B due to methylation abnormality combined with hypokalemia: A case report and review.
    Zhang Y; Song X; Zhang W; Qi T; Sun W; Zhou X
    Ann Endocrinol (Paris); 2022 Dec; 83(6):472-474. PubMed ID: 36371350
    [No Abstract]   [Full Text] [Related]  

  • 27. A patient with pseudohypoparathyroidism with increased serum calcium and 1 alpha, 25-dihydroxyvitamin D after exogenous parathyroid hormone administration.
    Lawoyin S; Norman DA; Zerwekh JE; Breslau NA; Pak CY
    J Clin Endocrinol Metab; 1979 Nov; 49(5):783-6. PubMed ID: 489718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
    Lambert PW; Hollis BW; Bell NH; Epstein S
    J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypomagnesemia masking the appearance of elevated parathyroid hormone concentrations in familial pseudohypoparathyroidism.
    Allen DB; Friedman AL; Greer FR; Chesney RW
    Am J Med Genet; 1988 Sep; 31(1):153-8. PubMed ID: 3223496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pseudoidiopathic hypoparathyroidism and pseudopseudohypoparathyroidism].
    Okazaki R
    Nihon Rinsho; 2006 Jun; Suppl 2():66-9. PubMed ID: 16817352
    [No Abstract]   [Full Text] [Related]  

  • 31. Hypocalcemia.
    Lebowitz MR; Moses AM
    Semin Nephrol; 1992 Mar; 12(2):146-58. PubMed ID: 1561494
    [No Abstract]   [Full Text] [Related]  

  • 32. Parathyroid Hormone Resistance and Bilateral Macronodular Adrenocortical Disease: Does Partial Loss of Methylation at the GNAS Exon 1 Differentially Methylated Region (DMR) Play a Role?
    Koch CA
    Horm Metab Res; 2017 Jul; 49(7):558-560. PubMed ID: 28395381
    [No Abstract]   [Full Text] [Related]  

  • 33. An epigenetic cause of seizures and brain calcification: pseudohypoparathyroidism.
    Ritter C; Göbel CH; Liebig T; Kaminksy E; Fink GR; Lehmann HC
    Lancet; 2015 May; 385(9979):1802. PubMed ID: 25943944
    [No Abstract]   [Full Text] [Related]  

  • 34. [Diagnostic image. A girl with cramp and tingling of the hands].
    Harnisch E; Sas TC
    Ned Tijdschr Geneeskd; 2009; 153():B411. PubMed ID: 19785817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies of hypoparathyroidism and pseudohypoparathyroidism.
    Lewin IG; Papapoulos SE; Tomlinson S; Hendy GN; O'Riordan JL
    Q J Med; 1978 Oct; 47(188):533-48. PubMed ID: 220660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic and molecular genetic aspects of pseudohypoparathyroidism type Ib in a Greek kindred: evidence for enhanced uric acid excretion due to parathyroid hormone resistance.
    Laspa E; Bastepe M; Jüppner H; Tsatsoulis A
    J Clin Endocrinol Metab; 2004 Dec; 89(12):5942-7. PubMed ID: 15579741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of parathyroid function in patients with a short history of hemodialysis.
    Nishi H; Sato T; Kurihara T; Kurosawa T; Fukagawa M
    Ther Apher Dial; 2005 Feb; 9(1):39-43. PubMed ID: 15828904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serum osteocalcin concentration in a patient with pseudohypoparathyroidism type Ib].
    Ichikawa T; Abe Y; Kanamori A; Yajima Y
    Nihon Naibunpi Gakkai Zasshi; 1991 Jul; 67(7):775-84. PubMed ID: 1889514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pseudohypoparathyroidism type I and vitamin D therapy].
    Kovarik J; Weissel M; Neuwirth G; Krepler P; Willvonseder R
    Acta Med Austriaca; 1978; 5(3):106-9. PubMed ID: 222102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progressive Development of PTH Resistance in Patients With Inactivating Mutations on the Maternal Allele of GNAS.
    Usardi A; Mamoune A; Nattes E; Carel JC; Rothenbuhler A; Linglart A
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1844-1850. PubMed ID: 28323910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.